Targeting human leukocyte antigen G with chimeric antigen receptors of natural killer cells convert immunosuppression to ablate solid tumors

BACKGROUND: Immunotherapy against solid tumors has long been hampered by the development of immunosuppressive tumor microenvironment, and the lack of a specific tumor-associated antigen that could be targeted in different kinds of solid tumors. Human leukocyte antigen G (HLA-G) is an immune checkpoi...

Descripción completa

Detalles Bibliográficos
Autores principales: Jan, Chia-Ing, Huang, Shi-Wei, Canoll, Peter, Bruce, Jeffrey N, Lin, Yu-Chuan, Pan, Chih-Ming, Lu, Hsin-Man, Chiu, Shao-Chih, Cho, Der-Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Immune Cell Therapies and Immune Cell Engineering
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524382/
https://www.ncbi.nlm.nih.gov/pubmed/34663641
http://dx.doi.org/10.1136/jitc-2021-003050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524382/
https://www.ncbi.nlm.nih.gov/pubmed/34663641
http://dx.doi.org/10.1136/jitc-2021-003050

Ejemplares similares